IL-23 and IL-17 Inhibitors Reduce Cardiovascular Outcomes in Statin-Treated Psoriasis Patients
Biologics significantly lower cardiovascular risks in psoriasis patients on statins, highlighting their dual benefits for skin and heart health.
Artax Biopharma's AX-158: A Novel Approach to T Cell-Driven Inflammation in Psoriasis
Scott Batty, MD, and Chris VanDeusen, PhD, provided insights on AX-158's phase 2a results, presented at the SID Annual Meeting.
Risankizumab Effective in Difficult-to-Treat Psoriasis Areas
Discover the promising results of risankizumab for treating genital and scalp psoriasis, showcasing significant improvements in symptoms and quality of life.
Recludix Unveils First BTK SH2 Domain Inhibitor
Recludix Pharma unveils a groundbreaking BTK SH2 inhibitor, showcasing superior selectivity and efficacy for chronic spontaneous urticaria treatment at SID 2025.
Prolonged Use of Oral Corticosteroids in Atopic Dermatitis Linked to Increased Cardiovascular Risks
Extended oral corticosteroid therapy in patients with atopic dermatitis significantly increases cardiovascular and thrombotic risks, urging careful treatment evaluations.
Dual Inhibitor TRIV-509 Shows Promise for Rapid Improvement in Atopic Dermatitis
Researchers reveal TRIV-509, a novel monoclonal antibody, shows promise in rapidly improving atopic dermatitis by restoring skin barrier integrity and reducing inflammation.
Icotrokinra Effective in High-Impact Psoriasis Areas
Johnson & Johnson's icotrokinra shows promising results in treating moderate plaque psoriasis, especially in challenging areas like the scalp and genitals.
Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis
The promising safety and efficacy results were presented at the Society for Investigative Dermatology 2025 Annual Meeting.
Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial
Selective ITK inhibition with oral soquelitinib led to early and durable clinical responses, cytokine reduction, and increased T regulatory cells.
Dermatology Conferences and Meetings Calendar: May 2025
Dermatology Times has compiled a list of dermatological meetings taking place during the month of May.
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
Discover how the RAD conference in Nashville enhances atopic dermatitis care, featuring expert insights and patient-focused strategies for clinicians.
Upadacitinib Outpaces Dupilumab in Rapid AD Symptom Control
Discover how upadacitinib outperforms dupilumab in providing rapid itch relief for moderate-to-severe atopic dermatitis in a recent AAD study.
Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)
Dermatology undergoes rapid transformation with new therapies, but faces challenges in payment reform, certification awareness, and balancing technology with patient care.
Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel
Paller discusses the promising phase 3 trial SELVA trial results for Qtorin 3.9% rapamycin gel, an investigative treatment for microcystic lymphatic malformations.
Expert Insights From AAD 2025
From our April issue: Unlock exclusive AAD 2025 insights from top dermatology experts—what you missed and what’s next.
One-Stop Shop: RAD Offers Comprehensive Insights Into AD Diagnosis, Treatment, and Research
Raj Chovatiya, MD, PhD, MSCI, reviews the benefits of Revolutionizing Atopic Dermatitis as a disease-specific conference.
Nonsteroidal Tapinarof Cream Provides Long-Lasting AD Relief
Tapinarof offers sustained relief for atopic dermatitis, enabling treatment-free periods and long-term disease control—even in young children.
Icotrokinra Demonstrates Efficacy in Adolescents and Adults With Moderate to Severe Psoriasis in ICONIC-LEAD Phase 3 Study
A new subgroup analysis revealed higher rates of clear or almost clear skin at week 16 vs placebo with a favorable safety profile.
Exploring the 2025 Revolutionizing Atopic Dermatitis (RAD) Annual Meeting Agenda
Get a glimpse of the cutting-edge atopic dermatitis research, breakthroughs, and insights to be presented at the 7th RAD Annual Meeting, June 6-7, 2025.
Dermatology Conferences and Meetings Calendar: April 2025
Dermatology Times has compiled a list of dermatological meetings taking place during the month of April.